Advantage Alpha Capital Partners »

Entrada Therapeutics shares owned by Advantage Alpha Capital Partners

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Advantage Alpha Capital Partners from 13F filings

Historical chart of Advantage Alpha Capital Partners investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Advantage Alpha Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Advantage Alpha Capital Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.3M 91k 14.17